| __timestamp | Teva Pharmaceutical Industries Limited | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5078000000 | 7751000 |
| Thursday, January 1, 2015 | 4717000000 | 10251000 |
| Friday, January 1, 2016 | 5096000000 | 9575000 |
| Sunday, January 1, 2017 | 4986000000 | 10912000 |
| Monday, January 1, 2018 | 4214000000 | 11049000 |
| Tuesday, January 1, 2019 | 3806000000 | 11646000 |
| Wednesday, January 1, 2020 | 3671000000 | 13265000 |
| Friday, January 1, 2021 | 3528000000 | 25805000 |
| Saturday, January 1, 2022 | 3445000000 | 35182000 |
| Sunday, January 1, 2023 | 3498000000 | 94999000 |
| Monday, January 1, 2024 | 3702000000 |
Cracking the code
In the ever-evolving pharmaceutical landscape, understanding the financial health of companies is crucial. Over the past decade, Teva Pharmaceutical Industries Limited and Viridian Therapeutics, Inc. have shown contrasting trends in their Selling, General, and Administrative (SG&A) expenses.
Teva, a global leader, has seen a significant reduction in SG&A expenses, dropping approximately 32% from 2014 to 2023. This decline reflects strategic cost-cutting measures and operational efficiencies. In contrast, Viridian, a smaller player, has experienced a dramatic increase in SG&A expenses, surging over 1,100% during the same period. This rise indicates aggressive expansion and investment in growth initiatives.
These trends highlight the differing strategies of established giants and emerging innovators in the pharmaceutical sector. As Teva focuses on streamlining, Viridian is investing heavily in its future, setting the stage for an intriguing competitive dynamic.
Breaking Down SG&A Expenses: GSK plc vs Viridian Therapeutics, Inc.
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Intra-Cellular Therapies, Inc.
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
SG&A Efficiency Analysis: Comparing Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S
Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated: SG&A Expense Trends
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Viridian Therapeutics, Inc.'s Expenses
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Viridian Therapeutics, Inc.
Selling, General, and Administrative Costs: Bio-Techne Corporation vs Viridian Therapeutics, Inc.
Xenon Pharmaceuticals Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Xencor, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared